Sphingosine synergistically stimulates tumor necrosis factor α-induced prostaglandin E2 production in human fibroblasts

Journal of Experimental Medicine

Volumn 174, Issue 6, 1991, Pages 1363-1369

  Candela, Marco ^b   Barker, Sean C ^a   Ballou, Leslie R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROTEIN KINASE C; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SPHINGOSINE; SPHINGOSINE DERIVATIVE;

ARTICLE; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL LINE; DINOPROSTONE; DRUG SYNERGISM; FIBROBLASTS; HUMAN; INTERLEUKIN-1; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE; PROTEIN KINASE C; PROTEINS; SPHINGOSINE; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR;

EID: 0025837202     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.174.6.1363     Document Type: Article

References (46)

1. Hannun, Y.A., and R.M. Bell. 1989. Function of sphingolipids and sphingolipid breakdown products in cellular recognition. Science (Wash. DC). 243:500.
2. Hanai, N., G. Nores, C.R. Torres Mendez, and S. Sakomori. 1987. Modified ganglioside as a possible modulator of transmembrane signaling mechanism through growth factor receptors: a preliminary note. Biochem. Biophys. Res. Commun. 147:127.
3. Hall, F.L., P. Femyhough, D.N. Ishii, and P.R. Vulliet. 1988. Suppression of nerve growth factor-directed neurite outgrowth in PC12 cells by sphingosine, an inhibitor of protein kinase C. J. Biol. Chem. 263:4460.
4. Faucher, M., N. Girones, Y.A. Hannun, R.M. Bell, and R.J. Davis. 1988. Regulation of epidermal growth factor receptor phosphorylation state by sphingosine in A431 human epidermoid carcinoma cells. J. Biol. Chem. 263:5319.
5. Davis, R.J., N. Girones, and M. Faucher. 1988. Two alternative mechanisms control the interconversion of functional states of the epidermal growth factor receptor. J. Biol. Chem. 263:5373.
6. Malinow, R., D.V. Madison, and R.W. Tsien. 1988. Persistent protein kinase activity underlying long term potentiation. Nature (bond.). 335:820.
7. Hannun, Y.A., C.R. Loomis, A.H. Merrill, Jr., and R.M. Bell. 1986. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem. 261:12604.
8. Wilson, E., M.C. Olcott, R.M. Bell, A.H. Merrill, Jr., and J.D. Lambeth. 1986. Inhibition of the oxidase burst in human neutrophils by sphingoid long-chain bases: roles of protein kinase C activation in the burst. J. Biol. Chem. 261:12616.
9. Jefferson, A.B., and H. Schulman. 1988. Sphingosine inhibits calmodulin-dependent enzymes. J. Biol. Chem. 263:15241.
10. Merrill, A.H., Jr., A.M. Sereni, V.L. Stevens, Y.A. Hannun, R.M. Bell, andJ.M. Kinkade, Jr. 1986. Inhibition of phorbol ester-dependent differentiation of human promyelocytic leukemic (HL60) cells by sphinganine and other long-chain bases. J. Biol. Chem. 261:12610.
11. Gupta, A.K., G.J. Fisher, J.T. Elder, B.J. Nickoloff, and J.J. Voorhees. 1988. Sphingosine inhibits phorbol ester-induced inflammation, ornithine decarboxylase activity, and activation of protein kinase C in mouse skin.J. Invest. Dermatol. 91:486.
12. Grove, D.D., and A.M. Mastro. 1988. Prevention of the TPA-mediated down-regulation of protein kinase C. Biochem. Bio-phys. Res. Commun. 151:94.
13. Merrill, A.H., Jr., and V.L. Stevens. 1989. Modulation of protein kinases C and diverse cell functions by sphingosine - a pharmacologically interesting compound linking sphingolipids and signal transduction. Biochim. Biophys. Acta. 1010:131.
14. Bell, R.M. 1986. Protein kinase C activation by diacylglycerol second messengers. Cell. 45:631.
15. Nishizuka, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumour production. Nature (Lortd.). 308:693.
16. Zhang, H., N.E. Buckley, K. Gibson, and S. Spiegel. 1990. Sphingosine stimulates cellular proliferation via a protein kinase C independent pathway. J. Biol. Chem. 265:76.
17. Zhang, H., N.N. Desai, J.M. Murphy, and S. Spiegel. 1990. Increases in phosphatidic acid levels accompany sphingosine-stimulated proliferation of quiescent Swiss 3T3 cells. J. Biol. Chem. 265:21309.
18. Ballou, L.R., S.C. Barker, A.E. Postlethwaite, and A.H. Kang. 1990. Sphingosine potentiates IL-1 mediated PGE2 production in human fibroblasts. J. Immunol. 145:4245.
19. Beutler, R, J. Mahoney, N. Le Trang, P. Bekala, and A. Cerami. 1985. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J. Exp Med. 161:984.
20. Old, L.J. 1987. Tumor necrosis factor. Polypeptide mediator network. Nature (Lond.). 326:330.
21. Beutler, B., and A. Cerami. 1988. Tumor necrosis cachexia, shock and inflammation: a common mediator. Annu. Rev. Biochem. 57:505.
22. Tsujimoto, M., R. Feinmann, M.Y. Kohase, andj. Vilcek. 1986. Characterization and affinity crosslinking of receptors for tumor necrosis factor on human cells. Arch. Biochem. Biophys. 249:563.
23. Scheurich, P., U. Ucer, M. Kronke, and K. Pfizenmaier. 1986. Quantification and characterization of high affinity membrane receptors for tumor necrosis factor on human leukemic cell lines. Int. J. Cancer. 38:127.
24. Kovack, E.J., D. Radzioch, H.A. Young, and L. Varesio. 1988. Differential inhibition of IL-1 and TNFa mRNA expression by agents which block second messenger pathways in murine macrophages. J. Immunol. 141:3101.
25. Brenner, D.A., M. Ohara, P. Angel, M. Chojkier, and M. Karin. 1989. Prolonged activation of jun and collagenase genes by tumor necrosis factor a. Nature (Lond.). 337:661.
26. Schutze, S., S. Nottrott, K. Pfizenmaier, and M. Kronke. 1990. Tumor necrosis factor signal transduction: cell type-specific activation and translation of protein kinase C. J. Immunol. 144:2604.
27. Meichle, A., S. Schutze, G. Hensel, D. Brunsing, and M. Kronke. 1990. Protein kinase C independent activation of nuclear factor kB by tumor necrosis factor.Biol. Chem. 265:8339.
28. Kim, M.Y., C. Linardic, L. Obeid, and Y.A. Hannun. 1991. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor a and y-interferon. Specific role in cell differentiation. J. Biol. Chem. 266:484.
29. 2 from fibroblasts. Br. J. Rheumatol. 24(Suppl.):122.
30. Dayer, J.-M., B. Beutler, and A. Cerami. 1985. Cachectin/ tumor necrosis factor stimulates collagenases and prostaglandin E production by human synovial cells and dermal fibroblasts. J. Exp Med. 162:2163.
31. Postlethwaite, A.E., L.B. Lachman, and A.H. Kang. 1984. Induction of fibroblast proliferation by IL-1 derived from human monocytic leukemia cells. Arthritis Rheum. 27:995.
32. Le, J., and J. Vilcek. 1987. Biology of disease. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lah Invest. 56:234.
33. Elias, J.A., K. Gustilo, W. Baeder, and B. Freundlich. 1987. Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J. Immunol. 138:3812.
34. Vilcek, J., M. Tsujimoto, V.T. Palombella, M. Kohase, andj. Le. 1987. Tumor necrosis factor: receptor binding and mito-genic action in fibroblasts. J. Cell. Physiol. 5:57.
35. Dinarello, C.A., J.G. Cannon, S.M. Wolff, H.A. Bernheim, B. Beutler, A. Cerami, I.S. Figari, M.A. Palladino, Jr., and J.V. O’Connor. 1986. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp Med. 163:1433.
36. Hannum, C.H., C.J. Wilcox, W.P. Arend, F.G. Joslin, D.J. Dripps, P.L. Heimdal, L.G. Armes, A. Sommer, S.P. Eisenberg, and R.C. Thompson. 1990. Interleukin 1 receptor antagonist activity of a human interleukin 1 inhibitor. Nature (Lond.). 343:336.
37. Ballou, L.R., and W.Y. Cheung. 1983. Marked increase of human platelet phospholipase A2 activity in vitro and demonstration of an endogenous inhibitor. Proc Natl. Acad. Sci. USA. 80:5203.
38. 2 activity by unsaturated fatty acids. Proc. Natl. Acad. Sci. USA. 82:371.
39. 2. J. Biol. Chem. 261:3107.
40. 2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells. Biochem. Biophys. Res. Commun. 120:1053.
41. Hovis, J.G., D.J. Stumpo, D.L. Halsey, and P.J. Blackshear. 1986. Effects of mitogen on ornithine decarboxylase activity and messenger RNA levels in normal and protein kinase C-deficient NIH-373 fibroblasts. J. Biol. Chem. 261:10380.
42. Raz, A., A. Wyche, N. Siegel, and P. Needleman. 1988. Regulation fibroblast cyclooxygenase synthesis by interleukin 1. J. Biol. Chem. 263:3022.
43. Ghosh, T.K., J. Bian, and D.L. Gill. 1990. Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science (Wash. DC). 248:1653.
44. Hakomori, S. 1990. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J. Biol. Chem. 265:18713.
45. Okazaki, T., A. Bielawaka, R.M. Bell, and Y.A. Hannun. 1990. Role of ceramide as a lipid mediator of la, 25-dihydroxivitamin Dj-induced HL-60 cell differentiation. J. Biol. Chem. 265:15823.
46. 2 production by blocking mRNA synthesis and post-transcriptional expression. J. Biol. Chem. 265:12745.